LGN - Company ID 0002052568
The table below shows Legence Corp.'s income statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q1 2026 | Q4 2025 | Q3 2025 | Q1 2025 | Q3 2024 |
|---|---|---|---|---|---|
| Revenue | $1.04B | - | $708.01M | $505.95M | $560.80M |
| Cost of revenue | $851.74M | - | $559.95M | $394.25M | $442.26M |
| Gross profit | $186.15M | - | $148.06M | $111.70M | $118.55M |
| R&D | - | - | - | - | - |
| SG&A | $116.09M | - | $85.89M | $69.46M | $67.20M |
Legence Corp. reported annual revenue of $2.55B for fiscal year 2025. That is up 21.5% from $2.10B in fiscal 2024. Figures come from the company's audited annual reports as filed with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Operating income | $22.37M | - | $37.20M | $16.55M | $26.95M |
| Income tax | -$13.38M | - | $4.08M | $4.04M | $4.56M |
| Net income | $16.09M | - | -$576.00K | -$21.21M | -$1.08M |
| EPS (diluted) | $0.13 | -$0.57 | - | - | - |